What's Going On With Regencell Bioscience Stock Today?

Regencell Bioscience Holdings (NASDAQ:RGC) shares are soaring Monday after the company’s 38-for-one forward stock split officially took effect.

What To Know: The split, announced at the beginning of June and distributed on June 13, gave shareholders 37 additional shares for each one they already owned. The stock began trading on a split-adjusted basis on Monday. The company stated that the goal of the split was to improve liquidity and make its shares more accessible to investors.

Regencell is an early-stage bioscience company based in Hong Kong. The company focuses on developing traditional Chinese medicine treatments for neurological disorders, specifically ADHD and autism spectrum disorder.

The stock split doesn't alter the company's ...